Market Place
Sourcing Support
Hummingbird Bioscience Presents HMBD-802 at EORTC-NCI-AACR
23 Oct 2024 //
GLOBENEWSWIRE
Hummingbird Bioscience Appoints New CMO and COO
29 Jul 2024 //
CONTRACT PHARMA
Hummingbird Presents Next-Gen ADC Data At PEGS Boston 2024
13 May 2024 //
GLOBENEWSWIRE
Hummingbird and Dartmouth`s Geisel School of Medicine to Co-Host VISTA Symposium
13 Mar 2024 //
PR NEWSWIRE
Hummingbird to Present Posters on Anti-HER3 and Anti-VISTA Antibody Therapeutics
05 Mar 2024 //
PR NEWSWIRE
Hummingbird Strengthens Leadership Team with Appointment of Angèle Maki as CBO
11 Dec 2023 //
PR NEWSWIRE
Hummingbird Bioscience Announces Positive Phase I Clinical Data for HMBD-001
23 Oct 2023 //
PR NEWSWIRE
Endeavor signs $430M deal for Hummingbird’s HER3-targeted ADC
20 Oct 2023 //
FIERCE BIOTECH
Hummingbird Bioscience and Merck Enter Collaboration to Evaluate HMBD-001
15 May 2023 //
PR NEWSWIRE
Hummingbird and Merck to evaluate combination therapy for NSCLC
15 May 2023 //
CLINICAL TRIALS ARENA
Hummingbird to Present Preclinical Proof of Concept for First-In-Class Antibody
08 May 2023 //
PR NEWSWIRE
George Clinical to Support Hummingbird’s Phase 1 Oncology Trials
04 May 2023 //
CONTRACT PHARMA
Hummingbird Exercises Its Option to License Trial Results to Support HMBD-001
06 Mar 2023 //
PR NEWSWIRE
Hummingbird Bio buzzes Synaffix for $150M ADC licensing deal
05 Jan 2023 //
FIERCE BIOTECH
Caris Life Sciences and Hummingbird Bioscience Enter Strategic Collaboration
06 Dec 2022 //
CONTRACTPHARMA
Hummingbird Bioscience to Attend the Credit Suisse 31st Annual Healthcare
01 Nov 2022 //
PRNEWSWIRE
Hummingbird Bioscience opens research facilities at Singapore Science Park
26 Sep 2022 //
BIOSPECTRUMASIA
Hummingbird CSO Jerome Boyd-Kirkup to Present at Annual VISTA Virtual Symposium
19 Sep 2022 //
PRNEWSWIRE
Hummingbird to Participate in the Morgan Stanley Global Healthcare Conference
06 Sep 2022 //
PRNEWSWIRE
Hummingbird Publishes Study of miRisk as Predictor of Immunotherapy Efficacy
23 Jun 2022 //
BUSINESSWIRE
Hummingbird begins dosing with HMBD-001 in Phase I cancer trial
06 Dec 2021 //
CLINICALTRIALSARENA
Hummingbird Begins Dosing in Phase 1 of HMBD-001 in HER3-Expressing Malignancies
06 Dec 2021 //
PRNEWSWIRE
Hummingbird Announces Trials in Progress Poster Presentation at the Society
10 Nov 2021 //
PRNEWSWIRE
Hummingbird to Collaborate with Merck on Trial of Anti-VISTA Antibody HMBD-002
25 Oct 2021 //
PRNEWSWIRE
FDA Clears Hummingbird`s IND for PI Trial of HMBD-002 in Advanced Solid Tumors
13 Sep 2021 //
PRNEWSWIRE
Hummingbird gets UK MHRA approval to initiate phase 1 trial of HMBD-001
02 Aug 2021 //
PHARMABIZ
Hummingbird Bioscience and MD Anderson Announce Research Collaboration
12 Jul 2021 //
PRNEWSWIRE
Hummingbird Bioscience inks research pact with MD Anderson Cancer Center
12 Jul 2021 //
PHARMABIZ
Hummingbird Bioscience and Novogene enter into strategic partnership
09 Jun 2021 //
PRNEWSWIRE
Hummingbird collaborates with Tempus to harness AI-driven precision medicine
15 Dec 2020 //
BIOSPECTRUMASIA
Hummingbird closes extended Series B funding round of $25M
11 May 2020 //
PR NEWSWIRE
Hummingbird Bioscience Announces Agreement with Mycenax Biotech HMBD-002
20 Feb 2020 //
YAHOO
Hummingbird Bio raises $19M in Series B round
04 Dec 2019 //
BIOSPECTRUM ASIA
Hummingbird Bioscience Raises US$19 Million in Series B Financing
02 Dec 2019 //
PRESS RELEASE
Cancer Research UK collaborates with Hummingbird Bioscience
09 Aug 2019 //
BIOSPECTRUMASIA
Hummingbird Bioscience Awarded $13.1 M Grant by (CPRIT)
25 Feb 2019 //
BIOSPACE
Hummingbird Bioscience, Sanofi to develop novel cancer therapeutics
21 Apr 2016 //
BIOSPECTRUM ASIA
